| Hypoxia-targeted drug delivery A Sharma, JF Arambula, S Koo, R Kumar, H Singh, JL Sessler, JS Kim Chemical Society Reviews 48 (3), 771-813, 2019 | 377 | 2019 |
| A simple ligand that selectively targets CUG trinucleotide repeats and inhibits MBNL protein binding JF Arambula, SR Ramisetty, AM Baranger, SC Zimmerman Proceedings of the National Academy of Sciences 106 (38), 16068-16073, 2009 | 256 | 2009 |
| A pyrrolyl-based triazolophane: a macrocyclic receptor with CH and NH donor groups that exhibits a preference for pyrophosphate anions JL Sessler, J Cai, HY Gong, X Yang, JF Arambula, BP Hay Journal of the American Chemical Society 132 (40), 14058-14060, 2010 | 145 | 2010 |
| Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future S Sen, M Won, MS Levine, Y Noh, AC Sedgwick, JS Kim, JL Sessler, ... Chemical Society Reviews 51 (4), 1212-1233, 2022 | 118 | 2022 |
| Targeting antioxidant pathways with ferrocenylated N-heterocyclic carbene supported gold (I) complexes in A549 lung cancer cells JF Arambula, R McCall, KJ Sidoran, D Magda, NA Mitchell, CW Bielawski, ... Chemical science 7 (2), 1245-1256, 2016 | 95 | 2016 |
| Overcoming drug resistance by targeting cancer bioenergetics with an activatable prodrug A Sharma, MG Lee, H Shi, M Won, JF Arambula, JL Sessler, JY Lee, ... Chem 4 (10), 2370-2383, 2018 | 81 | 2018 |
| Recent developments in texaphyrin chemistry and drug discovery C Preihs, JF Arambula, D Magda, H Jeong, D Yoo, J Cheon, ZH Siddik, ... Inorganic chemistry 52 (21), 12184-12192, 2013 | 81 | 2013 |
| Targeting heterogeneous tumors using a multifunctional molecular prodrug A Sharma, MG Lee, M Won, S Koo, JF Arambula, JL Sessler, SG Chi, ... Journal of the American Chemical Society 141 (39), 15611-15618, 2019 | 74 | 2019 |
| Activation of platinum (IV) prodrugs by motexafin gadolinium as a redox mediator G Thiabaud, R McCall, G He, JF Arambula, ZH Siddik, JL Sessler Angewandte Chemie International Edition 55 (41), 12626-12631, 2016 | 72 | 2016 |
| Rationally designed redox-active Au (I) N-heterocyclic carbene: an immunogenic cell death inducer S Sen, S Hufnagel, EY Maier, I Aguilar, J Selvakumar, JE DeVore, ... Journal of the American Chemical Society 142 (49), 20536-20541, 2020 | 68 | 2020 |
| Dual targeting of the cancer antioxidant network with 1, 4-naphthoquinone fused gold (i) N-heterocyclic carbene complexes R McCall, M Miles, P Lascuna, B Burney, Z Patel, KJ Sidoran, ... Chemical science 8 (9), 5918-5929, 2017 | 68 | 2017 |
| 2D-ultrathin MXene/DOXjade platform for iron chelation chemo-photothermal therapy Y Xu, Y Wang, J An, AC Sedgwick, M Li, J Xie, W Hu, J Kang, S Sen, ... Bioactive Materials 14, 76-85, 2022 | 57 | 2022 |
| Photoinduced Reduction of PtIV within an Anti‐Proliferative PtIV–Texaphyrin Conjugate G Thiabaud, JF Arambula, ZH Siddik, JL Sessler Chemistry–A European Journal 20 (29), 8942-8947, 2014 | 56 | 2014 |
| Oxaliplatin Pt (IV) prodrugs conjugated to gadolinium-texaphyrin as potential antitumor agents G Thiabaud, G He, S Sen, KA Shelton, WB Baze, L Segura, J Alaniz, ... Proceedings of the National Academy of Sciences 117 (13), 7021-7029, 2020 | 52 | 2020 |
| Lanthanide porphyrinoids as molecular theranostics GQ Jin, CV Chau, JF Arambula, S Gao, JL Sessler, JL Zhang Chemical Society Reviews 51 (14), 6177-6209, 2022 | 41 | 2022 |
| Expanded porphyrins: functional photoacoustic imaging agents that operate in the NIR-II region J Chen, AC Sedgwick, S Sen, Y Ren, Q Sun, C Chau, JF Arambula, ... Chemical Science 12 (29), 9916-9921, 2021 | 39 | 2021 |
| Manganese (II) texaphyrin: A paramagnetic photoacoustic contrast agent activated by near-IR light Y Ren, AC Sedgwick, J Chen, G Thiabaud, CV Chau, J An, JF Arambula, ... Journal of the American Chemical Society 142 (38), 16156-16160, 2020 | 39 | 2020 |
| A texaphyrin–oxaliplatin conjugate that overcomes both pharmacologic and molecular mechanisms of cisplatin resistance in cancer cells JF Arambula, JL Sessler, ZH Siddik MedChemComm 3 (10), 1275-1281, 2012 | 33 | 2012 |
| Mitochondrial relocation of a common synthetic antibiotic: A non-genotoxic approach to cancer therapy K Sunwoo, M Won, KP Ko, M Choi, JF Arambula, SG Chi, JL Sessler, ... Chem 6 (6), 1408-1419, 2020 | 31 | 2020 |
| Porphyrinoid Drug Conjugates JF Arambula, JL Sessler Chem 6 (7), 1634-1651, 2020 | 30 | 2020 |
